Global Interbody Fusion Cage Market - 2022-2029

Global Interbody Fusion Cage Market - 2022-2029

Market Overview

The global interbody fusion cage market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029).

The interbody fusion cage is a man-made medical device used in spinal fusion surgeries to preserve foraminal height and decompression. The interbody fusion cage is a huge, hollow metal cylinder of titanium, carbon fiber, or allograft femur. The device is designed as a cage to allow a bone graft to be inserted within the hollow cylinder to allow spinal fusion between two vertebrae. Source: DataM Intelligence Analysis (2021)

Market Dynamics

The rise in demand for interbody fusion cage procedures, as well as an increase in the senior population, have fueled the expansion of the global interbody fusion cage market.

Rapid technical advancements in cage design and material to increase fusion rate will drive the market growth

The global interbody fusion cages market is predicted to develop significantly during the forecast period, owing to an increase in demand for interbody fusion cage operations, which allow the surgeon to decompress nerves and reconstruct the spine directly. Furthermore, the main drivers driving market growth include an increase in the geriatric population and an increase in the incidence of spinal cord injuries caused by accidents and diseases such as degenerative disc disease. Furthermore, increasing disposable income in developing economies such as India and China contributes to market growth.

Rapid technical advancements in cage design and material to increase fusion rate and lower subsidence rates are projected to fuel market revenue growth. These cages are either metal or absorbable materials and can be implanted either surgically or endoscopically. Interbody cages support the anterior spine, increase bony apertures to offer greater space for spinal nerves to relieve discomfort and compression, promote solid fusion of neighboring vertebral segments by accelerating bone growth, and improve spinal segment balance. Interbody cages and spinal fusion operations also treat and cure spinal abnormalities. According to research investigations, interbody cages can achieve 70–95 percent cervical spinal fusion. Extensive research and development operations to produce superior interbody cages have resulted in increased investment by leading market players, which is another significant factor projected to fuel market revenue growth in the future.These factors are likely to boost the Interbody Fusion Cage market.

The high cost of spinal fusion operations is likely to hamper the market growth

However, the high cost of spinal fusion operations, a shortage of experienced experts, and a rise in disposable incomes in emerging economies are restraining the growth of the Interbody fusion cages market.

COVID-19 Impact Analysis

The COVID-19 pandemic has impacted workflows in the healthcare sector worldwide. The sickness has temporarily compelled several industries, including numerous healthcare subcategories, to temporarily close their doors. Furthermore, there has been a negative impact on various services, including the interbody fusion cage sector. According to the Commonwealth Fund, COVID-19 will result in a roughly 60 percent initial decrease in overall outpatient visits by May 2020. This was expected to negatively impact demand for interbody fusion cages for spinal fusions, which are often performed in outpatient departments. Furthermore, the pandemic has affected outpatient clinics, emergency and elective surgery, rehabilitation, resident training, personnel management, personal protective equipment, telemedicine, and all sub-specialties of orthopedics that perform spinal procedures, according to an article published in Europe PMC.

The COVID-19 has impacted the interbody fusion cage industry because hospital and healthcare services were drastically reduced as a result of social distancing measures implemented by governments around the world. Furthermore, the COVID-19 pandemic impacted the global economy and significantly influenced the operation of available medical treatment for non-COVID-19 patients in hospitals around the world.

Segment Analysis

The lumar cage segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The lumbar cage segment was the leading revenue contributor in 2020. This trend is expected to continue during the forecast period, owing to an increase in cervical fusion surgeries, which preserve spinal motion, do not require bone grafting or cervical disc replacement, and do not require a plate to be placed directly in front of the spine.

Cervical spine injuries, ranging from severe to fatal, can result in sudden death in athletes participating in both contact and non-contact sports. Although the incidence rate for high school is minimal (0.07/100,000; 2.12/100,000 for college), this type of injury has a very high death rate. Each year, approximately 12,000 new occurrences of cervical spine injury are reported in the United States, with car incidents accounting for 42% of these cases. Sports account for around 8% of these cervical spine injuries (1,000 cases).(Source: Article by University of Connecticut).

Geographical Analysis

North America region holds the largest market share of the global interbody fusion cage market

North America is expected to account for a disproportionately large revenue share during the forecast period due to the establishment of robust healthcare facilities, an increase in the incidence of spinal injuries and trauma, an increase in cases of age-related spinal problems, and the availability of advanced implantable medical devices. Other major factors projected to fuel market revenue growth in the region include increasing technical breakthroughs, a favorable reimbursement scenario, and a strong presence of prominent market competitors.

In addition, organic and inorganic strategies such as mergers and acquisitions and partnerships within key market players will strengthen their product portfolio in the studied market which will drive the market. Also, several product launches in the market will lead to lucrative growth of the market. For instance, in October 2020, In the United States, Genesys Spine debuted the first 3D printed non-screw-based cervical solo cage. The cage comprises a 3D printed cervical interbody cage with titanium anchors that allow for bone fusion and fixation with anterior access and a shorter surgical process. Furthermore, advancements in various surgical devices from established key players, in the United States, are likely to drive the market growth in North America.

Competitive Landscape

The Interbody Fusion Cage market is a highly competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Aurora Spine Inc, Benvenue Medical Inc,Prodorth, Orthofix, Medtronic Plc, Zimmer Biomet Holdings Inc, NuVasive Inc, Johnson & Johnson, Ulrich Medical, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the Interbody Fusion Cage market globally. For instance, In February 2021, NGMedical, a German medical device manufacturer specializing in spinal devices, announced that its additively made titanium cervical BEE cage had obtained FDA regulatory clearance. The honeycomb-shaped cage considerably decreases the possibility of subsidence and allows for optimal fusion.

Lombard Medical Inc

Overview:

Lombard Medical Inc is a medical technology company that specializes in developing, manufacturing, and marketing endovascular stent grafts that address significant unmet needs in aortic aneurysm repair. Aorfix is an endovascular stent graft with an approved indication for repairing AAAs (Abdominal Aortic Aneurysms) in patients with aortic neck angulations ranging from 0 to 90 degrees; IntelliFlex is an abdominal aortic aneurysm stent-graft delivery system, and Altura Endovascular Stent Graft System is an ultra-low profile endovascular stent graft technology. Japan accounts for the majority of the company's revenue.

Product Portfolio:

The AlturaTM Endograft System: The AlturaTM Endograft System redefines simplicity in abdominal aortic aneurysm treatment with a unique bilateral D-stent design. AlturaTM is an excellent choice for a wide range of patients due to its revolutionary benefits.

Why Purchase the Report?

Visualize the composition of the global interbody fusion cage market segmentation by product type, surgery, end user, and region highlighting the key commercial assets and players.

Identify commercial opportunities in the global interbody fusion cage market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global interbody fusion cage market-level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global interbody fusion cage market report would provide access to an approximately 40+ market data table, 45+ figures, and in the range of 180-200 (approximate) pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Market Segmentation

Global Interbody Fusion Cage Market– By Product Type

Lumbar Cage

Cervical Cage

Thoraco-Lumbar Cage

Thoracic Cage

Global Interbody Fusion Cage Market- By Surgery

Anterior

Posterior

Lateral

Transforaminal

Global Interbody Fusion Cage Market– By End User

Ambulatory Surgical Centers

Hospitals

Clinics

Others

Global Interbody Fusion Cage Market- By Region

North America

Europe

Asia-Pacific

Middle East & Africa

South America